We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Nicole Ehrhardt

Nicole M. Ehrhardt MD

Assistant Professor of Medicine, University of Washington School of Medicine, University of Washington Medicine Diabetes Institute, Seattle, Washington

Dr. Ehrhardt graduated from Uniformed Services University and completed her Internal Medicine and Endocrinology training at Walter Reed Army Medical Center. She then served as an endocrinologist in the army for 8 years. After completing her service in the military, she joined the Medical Faculty Associates at George Washington University in Washington, D.C. from 2014-2020. Recently, she transitioned to The Diabetes Institute at University of Washington in Seattle, WA. Dr. Ehrhardt has always been interested in lifestyle changes and multi-disciplinary approaches to the treatment of disease processes.  Her original research was in the use of continuous glucose monitoring(CGM) in patients with type II diabetes and she recently completed a pilot study looking at CGM as a behavior modification tool in patients with diabetes. She currently has an investigator initiated grant to look at CGM in gestational diabetes population. She is also involved in tele-mentoring primary care physicians for complex diabetes management through the ECHO model. She is an advocate for technology and teaching whole body health to patients living with diabetes.

Disclosures

Dr. Ehrhardt has received a consulting fee from Novo Nordisk, received investigator-initiated grants from Dexcom and educational grants from MERCK and Novo Nordisk.

Recent Contributions to PracticeUpdate:

  1. Payments for Noninsulin Glucose-Lowering Drugs